Does ELOTUZUMAB Cause Anaemia? 119 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 119 reports of Anaemia have been filed in association with ELOTUZUMAB (EMPLICITI). This represents 3.5% of all adverse event reports for ELOTUZUMAB.
119
Reports of Anaemia with ELOTUZUMAB
3.5%
of all ELOTUZUMAB reports
36
Deaths
66
Hospitalizations
How Dangerous Is Anaemia From ELOTUZUMAB?
Of the 119 reports, 36 (30.3%) resulted in death, 66 (55.5%) required hospitalization, and 14 (11.8%) were considered life-threatening.
Is Anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELOTUZUMAB. However, 119 reports have been filed with the FAERS database.
What Other Side Effects Does ELOTUZUMAB Cause?
Plasma cell myeloma (339)
Death (234)
Malignant neoplasm progression (227)
Pneumonia (209)
Pyrexia (183)
Drug ineffective (137)
Neutropenia (133)
Thrombocytopenia (107)
Diarrhoea (105)
Fatigue (95)
What Other Drugs Cause Anaemia?
LENALIDOMIDE (5,322)
CARBOPLATIN (5,312)
RIBAVIRIN (5,130)
ASPIRIN (4,568)
CYCLOPHOSPHAMIDE (4,486)
RITUXIMAB (4,399)
DEXAMETHASONE (4,352)
ADALIMUMAB (3,994)
PACLITAXEL (3,949)
METHOTREXATE (3,913)
Which ELOTUZUMAB Alternatives Have Lower Anaemia Risk?
ELOTUZUMAB vs ELOXATIN
ELOTUZUMAB vs ELRANATAMAB
ELOTUZUMAB vs ELRANATAMAB-BCMM
ELOTUZUMAB vs ELTROMBOPAG
ELOTUZUMAB vs ELTROMBOPAG OLAMINE